Fredun Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: FREDUN BSE: 539730

₹1404.50

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #95 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Fredun Pharmaceuticals Limited (this stock)	774	16.7	11.9%	—	—	48	79	51

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹931 Cr

EV / EBITDA

8.4x

EV / Sales

1.26x

Market cap / Sales

1.04x

Earnings yield

6.00%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 228 Cr, up 90.4% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	228	21	13	₹23.8900
March 31, 2026	210	12	11	₹20.2200
Dec. 31, 2025	160	14	—	₹19.5300
Sept. 30, 2025	144	13	10	₹20.6100
June 30, 2025	119	9	—	₹14.3300
March 31, 2025	165	8	7	₹14.9800
Dec. 31, 2024	102	7	5	₹11.2900
Sept. 30, 2024	107	8	4	₹9.0500
June 30, 2024	78	6	4	₹8.7900
March 31, 2024	117	6	5	₹10.7700
Dec. 31, 2023	87	6	4	₹8.9900
Sept. 30, 2023	81	6	4	₹8.4000
June 30, 2023	61	4	2	₹5.2400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	228	213	161	145	120	167	103	107	79	118	87	82	62
Operating revenue	228	210	160	144	119	165	102	107	78	117	87	81	61
Other income	0	3	1	2	0	2	1	0	1	1	0	1	1
Operating expenses	195	184	135	123	103	150	89	93	68	107	76	72	54
Operating profit	32	26	25	21	17	15	12	13	9	10	10	9	7
Operating profit margin	14.2%	12.6%	15.8%	14.4%	13.9%	9.4%	12.1%	12.6%	11.9%	8.8%	11.7%	11.2%	11.1%
Depreciation	4	3	2	2	1	1	1	1	1	1	1	1	1
Interest	9	14	11	8	7	8	5	5	4	4	4	3	3
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	21	12	14	13	9	8	7	8	6	6	6	6	4
Tax	7	0	4	3	2	1	2	3	1	1	2	2	2
Net profit	13	11	—	10	—	7	5	4	4	5	4	4	2
EPS	23.89	20.22	19.53	20.61	14.33	14.98	11.29	9.05	8.79	10.77	8.99	8.40	5.24
Net profit (TTM)	—	—	—	—	—	21	19	18	17	16	14	14	13
EPS (TTM)	84.25	74.69	69.45	61.21	49.65	44.11	39.90	37.60	36.95	33.40	31.22	29.89	28.60

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	32.2%	36.4%	639^†	456^†	349^†	276^†	226^†	135^†	113^†	97^†	—	—
Operating revenue	32.2%	36.9%	633^†	452^†	347^†	274^†	222^†	132^†	110^†	95^†	58^†	59^†
Other income	—	—	6^†	5^†	2^†	2^†	4^†	4^†	3^†	2^†	—	—
Operating expenses	—	—	544^†	401^†	310^†	246^†	211^†	125^†	105^†	86^†	54^†	52^†
Operating profit	46.9%	67.3%	89^†	51^†	36^†	28^†	11^†	7^†	6^†	9^†	4^†	7^†
Operating profit margin	—	—	14.1%^†	11.2%^†	10.5%^†	10.2%^†	5.0%^†	5.2%^†	5.2%^†	9.7%^†	7.5%^†	11.3%^†
Depreciation	—	—	8^†	4^†	4^†	3^†	2^†	2^†	2^†	1^†	1^†	1^†
Interest	—	—	39^†	22^†	14^†	9^†	5^†	4^†	4^†	3^†	2^†	2^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	-1^†	0^†	-1^†	-0^†	-0^†
Profit before tax	37.9%	71.5%	48^†	28^†	21^†	18^†	9^†	3^†	3^†	6^†	3^†	2^†
Tax	—	—	10^†	7^†	6^†	7^†	2^†	—	—	—	—	—
Net profit	—	—	—	21^†	16^†	11^†	6^†	3^†	2^†	4^†	2^†	2^†
EPS	43.1%	59.1%	74.69^†	44.11^†	33.40^†	25.48^†	14.83^†	7.33^†	4.80^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	14.1%^†	11.2%^†	10.5%^†	10.2%^†	5.0%^†	5.2%^†	5.2%^†	9.7%^†	7.5%^†	11.3%^†
EBIT margin	13.7%^†	11.2%^†	10.1%^†	10.0%^†	6.0%^†	5.6%^†	6.2%^†	9.7%^†	7.9%^†	7.2%^†
PBT margin	7.5%^†	6.3%^†	6.2%^†	6.6%^†	3.9%^†	2.4%^†	2.3%^†	6.5%^†	4.5%^†	4.0%^†
Net margin	—	4.6%^†	4.5%^†	4.2%^†	2.9%^†	2.2%^†	1.7%^†	4.7%^†	3.0%^†	2.6%^†
Interest coverage	2.21x^†	2.26x^†	2.57x^†	2.96x^†	2.84x^†	1.77x^†	1.58x^†	2.99x^†	2.36x^†	2.24x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.68x	1.31x	—	—	—	—	—	—	—	—
Quick ratio	0.77x	0.57x	—	—	—	—	—	—	—	—
Debt to equity	0.80x	1.18x	—	—	—	—	—	—	—	—
Return on equity	—	14.7%^†	—	—	—	—	—	—	—	—
Return on assets	—	4.3%^†	—	—	—	—	—	—	—	—
Return on capital employed	25.1%^†	31.8%^†	—	—	—	—	—	—	—	—
Asset turnover	0.99x^†	0.93x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	26	-74	121	74	-47
March 31, 2025	-29	-6	39	6	-35

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	642	279	273	166	56	498	296	65	118	270
March 31, 2025	487	141	137	157	10	428	327	0	52	240

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.